EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Screening for Life: Perspectives From Adult Metabolic Specialists on Newborn Screening for Inherited Metabolic Diseases

Mirjam Langeveld iD, Sandra Sirrs iD, Daphne H Schoenmakers iD, Timothy Fazio iD, Melanie M van der Klauw iD, Francois Maillot, Reena Sharma, Christel Tran, Athanasia Ziagaki, Fanny Mochel

Journal of Inherited Metabolic Disease · 2025

DOI: 10.1002/jimd.70057 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Mirjam Langeveld und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism and Amsterdam Gastroenterology Endocrinology and Metabolism Research Institute, Amsterdam University Medic…. Hauptthemen laut MEDLINE: Neonatal Screening, Metabolism, Inborn Errors, Metabolic Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The number of inherited metabolic diseases (IMDs) in newborn screening (NBS) programs has increased significantly in the past decades. For some of the IMDs included in NBS (e.g., tyrosinemia type I), there are clear and substantial health benefits of NBS, while for others (e.g., very long chain acyl CoA dehydrogenase deficiency and 3‐methylcrotonyl CoA carboxylase 1 deficiency), this is less clear as NBS identifies individuals who are asymptomatic or have milder forms of the disease. Therefore, knowledge of the full disease spectrum (including later onset forms) is needed when setting diagnostic metabolite cut‐offs for NBS. Insights into the clinical, genetic and biochemical characteristics of different patient subsets can be used to redefine NBS protocols to identify patients with more severe forms of the disease who are most likely to benefit from identification in the newborn period. These insights require life‐long monitoring of individuals identified based on symptoms versus those identified by NBS to determine long‐term health outcomes and quantify the benefits of NBS. Adult metabolic specialists should be included in the development of NBS programs to provide data from this long‐term monitoring and to contribute specific knowledge about later onset phenotypes of the IMDs included in NBS programs. The goal should be to develop NBS programs that identify newborns that benefit from early disease detection and treatment, without increasing psychological, social and management burden for individuals who may develop disease in adulthood with milder phenotype or potentially even not at all.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal ScreeningMetabolism, Inborn ErrorsMetabolic DiseasesHumansInfant, NewbornAdult

Stichwörter der Autor:innen

adult metabolic specialistinherited metabolic diseaseslate onset diseasenewborn screening

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism and Amsterdam Gastroenterology Endocrinology and Metabolism Research Institute, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Department of Medicine, Division of Endocrinology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Child Neurology, Emma's Children's Hospital, Amsterdam UMC Location Vrije Universiteit and Amsterdam Leukodystrophy Center, Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Amsterdam, the Netherlan…
  • Metabolic Diseases Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Department of Medicine, Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia.
  • Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

ORCID-Profile: Mirjam Langeveld, Sandra Sirrs, Daphne H Schoenmakers, Timothy Fazio, Melanie M van der Klauw

Zitieren

APA

Langeveld, M., Sirrs, S., Schoenmakers, D. H., Fazio, T., van der Klauw, M. M., Maillot, F., Sharma, R., Tran, C., Ziagaki, A., & Mochel, F. (2025). Screening for Life: Perspectives From Adult Metabolic Specialists on Newborn Screening for Inherited Metabolic Diseases. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70057

Vancouver

Langeveld M, Sirrs S, Schoenmakers DH, Fazio T, van der Klauw MM, Maillot F, et al. Screening for Life: Perspectives From Adult Metabolic Specialists on Newborn Screening for Inherited Metabolic Diseases. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70057

BibTeX
@article{Langeveld2025,
  author = {Langeveld, Mirjam and Sirrs, Sandra and Schoenmakers, Daphne H and Fazio, Timothy and van der Klauw, Melanie M and Maillot, Francois and Sharma, Reena and Tran, Christel and Ziagaki, Athanasia and Mochel, Fanny},
  title = {Screening for Life: Perspectives From Adult Metabolic Specialists on Newborn Screening for Inherited Metabolic Diseases},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  doi = {10.1002/jimd.70057}
}
Kostenlos starten →